Morrison Jodie Pope
- SEC CIK
- 0001618247
In the past year, 3 open-market sale filings worth $285.5K and no purchases.
Current role at each company
- QTTB Q32 Bio Inc.CEOas of Aug 27, 2026
- VERV Verve Therapeutics, Inc.Directoras of Jul 28, 2025
- RNTX Rein Therapeutics, Inc.Directoras of Jun 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $285.5K
- 3 filings
- Net
- −$285.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Morrison Jodie Pope as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QTTB Q32 Bio Inc.
CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 (view filing)4:10 PM ET | Aug 25 | 2 days | Morrison Jodie PopeCEO | SSale | −9.85K | $16.56 | −$163.0K | −2.8%343.3K after | |
| Feb 27, 2026 (view filing) | Feb 25 | 2 days | Morrison Jodie PopeCEO | SSale | −9.90K | $4.51 | −$44.6K | −10.0%89.1K after | |
| Dec 4, 2025 (view filing) | Dec 2 | 2 days | Morrison Jodie PopeCEO | SSale | −22.5K | $3.46 | −$77.9K | −18.5%99.0K after | |
| Aug 28, 2025 (view filing) | Aug 26 | 2 days | Morrison Jodie PopeCEO | SSale | −10.5K | $1.80 | −$18.9K | −8.0%121.5K after |